Novo Nordisk AS (OCSE:NOVO B)
kr 757.3 9.7 (1.3%) Market Cap: 3.36 Til Enterprise Value: 3.35 Til PE Ratio: 35.72 PB Ratio: 27.97 GF Score: 97/100

Novo Nordisk A/S Annual Shareholders Meeting Transcript

Mar 24, 2022 / 01:00PM GMT
Release Date Price: kr365 (-2.28%)
Lars Fruergaard Jorgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

/- -

Good afternoon, and welcome to Novo Nordisk's Annual General Meeting 2022. We had planned for the Chair of the Board, Helge Lund, to be present with us here today. But unfortunately, due to COVID-19, Helge is unable to travel to Denmark. He joins us virtually from his home in Norway.

Helge, over to you.

Helge Lund;S;Independent Chairman of the Board
Novo Nordisk A

/-

Thank you, Lars, and good afternoon, and a warm welcome to Novo Nordisk Annual General Meeting 2022. My name is Helge Lund, and I'm the Chair of the Board of Directors. And let me start out by expressing how thrilled I am that we are able to conduct this Annual General Meeting as a hybrid, allowing for participation irrespective of your location and preference. And on behalf of the Board, a very warm welcome to you all, and thank you for joining us.

For those of you joining us online, please note that the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot